-+ 0.00%
-+ 0.00%
-+ 0.00%

Acumen Pharmaceuticals Q1 EPS $(0.33) Beats $(0.36) Estimate

Benzinga·05/12/2026 11:01:10
Listen to the news
Acumen Pharmaceuticals (NASDAQ:ABOS) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.36) by 8.33 percent. This is a 31.25 percent increase over losses of $(0.48) per share from the same period last year.